U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901114) titled 'A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers' on Oct. 22.
Brief Summary: To evaluate the bioequivalence and safety of "AJU-C719" and "C719R" in healthy adult subjects.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: Test Drug
AJU-C719
DRUG: Reference Drug
C719R
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....